PT - JOURNAL ARTICLE AU - Munish Kumar AU - Karthikeyan Subramanian AU - Karan Singh Tanwar AU - Arun Prabhahar AU - Smita Divyaveer AU - Ashwani Sood AU - Bhagwant Rai Mittal AU - Apurva Sood TI - Radioiodine Therapy in Patient with Differentiated Thyroid Cancer and End-Stage Renal Disease on Maintenance Hemodialysis: Case Report with Review of Literature AID - 10.2967/jnmt.121.261979 DP - 2022 Sep 01 TA - Journal of Nuclear Medicine Technology PG - 228--232 VI - 50 IP - 3 4099 - http://tech.snmjournals.org/content/50/3/228.short 4100 - http://tech.snmjournals.org/content/50/3/228.full SO - J. Nucl. Med. Technol.2022 Sep 01; 50 AB - Surgical resection followed by radioactive iodine (131I) therapy constitutes a standard treatment for differentiated thyroid cancer. 131I is normally excreted through the kidneys, and treatment of patients with end-stage renal disease on hemodialysis requires special attention to the dose of 131I, the timing of dialysis, and radiation safety. We present a case of end-stage renal disease in a postthyroidectomy patient on hemodialysis who required radioactive iodine ablation, and we review the literature.